Back

Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Atrial fibrillation - Stroke prevention Clinical ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

9 More presentations in this session

Presentation thumbnail
Early changes in FVIII and vWF plasma levels and activity in patients with paroxysmal atrial fibrillation.
Associate Professor M. Negreva (Varna, BG)
Abstract
Presentation thumbnail
Correlation of left atrial fractionation substrate and low voltage between sinus rhythm and atrial fibrillation: high density mapping study in persistent AF
Doctor J. Chen (Nanjing, CN)
Presentation thumbnail
Long-term impact of metabolic syndrome management on mortality in patients with atrial fibrillation
Associate Professor Y. Baek (Incheon, KR)
Abstract
Presentation thumbnail
A prediction rule for new-onset postoperative atrial fibrillation after off-pump coronary artery bypass graft surgery
Ms X. Feng (Beijing, CN)
Abstract Slides
Presentation thumbnail
Risk factors for atrial fibrillation at the age of 40 years: 24-year follow-up data from the Norwegian Age 40 program and the Akershus cardiac examination (ACE) 1950 Study
Doctor T. Berge (Baerum, NO)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Atrial fibrillation - Stroke prevention

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources